Influence of anti-interleukin (IL)-5/anti-IL-5 receptor-α treatment on work productivity in patients with severe eosinophilic asthma

被引：0
|
作者：
Drick, Nora [1 ,2 ]
Brinkmann, Lina [1 ]
Fuge, Jan [1 ,2 ]
Welte, Tobias [1 ,2 ]
Suhling, Hendrik [1 ,2 ]
机构：
[1] Hannover Med Sch, Dept Resp Med, Hannover, Germany
[2] German Ctr Lung Res DZL, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany
来源：
ERJ OPEN RESEARCH | 2023年 / 9卷 / 03期
关键词：
BURDEN;
D O I：
10.1183/23120541.00665-2022
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy
    Bakakos, Agamemnon
    Rovina, Nikoleta
    Bakakos, Petros
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)
  • [2] Real-life effectiveness of anti-IL-5(-receptor) antibody treatment in patients with severe eosinophilic asthma
    Korn, Stephanie
    Ehrhard, Lucas
    Voigt, Stefanie
    Buhl, Roland
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [3] Severe asthma: anti-IgE or anti-IL-5?
    Papathanassiou, Evgenia
    Loukides, Stelios
    Bakakos, Petros
    [J]. EUROPEAN CLINICAL RESPIRATORY JOURNAL, 2016, 3
  • [4] Anti-IL-5 treatments in severe eosinophilic asthma: real life datas
    Ozdel Ozturk, Betul
    Bavbek, Sevim
    [J]. TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2020, 68 (02): : 148 - 159
  • [5] Anti-IL-5 Biologicals Targeting Severe Late Onset Eosinophilic Asthma
    Ozyigit, Leyla Pur
    Ozturk, Ayse Bilge
    Bavhek, Sevim
    [J]. TURKISH THORACIC JOURNAL, 2020, 21 (01): : 61 - 68
  • [6] Mepolizumab. Anti-IL-5 monoclonal antibody therapy in patients with Severe Eosinophilic Asthma
    Buttler, Bogna
    Dewor, Robert
    [J]. ALERGIA ASTMA IMMUNOLOGIA, 2018, 23 (03): : 137 - 142
  • [7] Anti-IL-5/5Ra biologics improve work productivity and activity in severe asthma.
    Kuiper-Van der Valk, Hanna
    Hekking, Pieter-Paul
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [8] Treatment with interleukin (IL)-5/IL-5 receptor antibodies in patients with severe eosinophilic asthma and COPD
    Drick, Nora
    Fuge, Jan
    Seeliger, Benjamin
    Speth, Milan
    Vogel-Claussen, Jens
    Welte, Tobias
    Suhling, Hendrik
    [J]. ERJ OPEN RESEARCH, 2022, 8 (04)
  • [9] Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma
    Bagnasco, Diego
    Ferrando, Matteo
    Varricchi, Gilda
    Puggioni, Francesca
    Passalacqua, Giovanni
    Canonica, Giorgio Walter
    [J]. FRONTIERS IN MEDICINE, 2017, 4
  • [10] Anti-IL-5 therapy in patients with severe eosinophilic asthma – clinical efficacy and possible criteria for treatment response
    Nora Drick
    Benjamin Seeliger
    Tobias Welte
    Jan Fuge
    Hendrik Suhling
    [J]. BMC Pulmonary Medicine, 18
12345